SCHEMBL31408537

SCHEMBL31408537

COc1cnc(-c2cc3[nH]c(CNC(=O)N4CC(O)C4)cc3cc2Cl)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MAPK1 P28482 2/20 0.33
▸ PTGES O14684 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ CHRNA7 P36544 4/20 0.32
▸ BTK Q06187 2/20 0.32
▸ JAK2 O60674 1/20 0.31
▸ JAK3 P52333 1/20 0.31
▸ PTK2 Q05397 1/20 0.31
▸ JUN P05412 1/20 0.31
▸ MAPK8 P45983 1/20 0.31
▸ MAPK9 P45984 1/20 0.31
▸ MAPK10 P53779 1/20 0.31
▸ ALK Q9UM73 1/20 0.31
▸ P2RX7 Q99572 1/20 0.31
▸ PDCD1 Q15116 1/20 0.31
▸ CD274 Q9NZQ7 1/20 0.31
▸ MLLT1 Q03111 1/20 0.31
▸ MAP4K1 Q92918 1/20 0.31
▸ MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31408327 0.93 LRRK2 (0.35) SMN1; SMN2MAPK1LRRK2JAK2JAK3
SCHEMBL31408429 0.93 LRRK2 (0.35) SMN1; SMN2MAPK1LRRK2JAK2JAK3
SCHEMBL31408237 0.93 LRRK2 (0.35) SMN1; SMN2MAPK1LRRK2JAK2JAK3
SCHEMBL31408437 0.90 SMN1; SMN2 (0.34) SMN1; SMN2MAPK1PTGESLRRK2CHRNA7
SCHEMBL31408430 0.90 MAPK1 (0.37) SMN1; SMN2MAPK1PTGESALKMLLT1
SCHEMBL31408514 0.88 SMN1; SMN2 (0.36) SMN1; SMN2MAPK1PTGESCHRNA7PDCD1
SCHEMBL31408279 0.88 SMN1; SMN2 (0.36) SMN1; SMN2MAPK1PTGESLRRK2ALK
SCHEMBL31408356 0.87 POLB (0.39) SMN1; SMN2MAPK1LRRK2MLLT1MEN1
SCHEMBL31408404 0.86 LRRK2 (0.36) SMN1; SMN2MAPK1PTGESLRRK2CHRNA7
SCHEMBL31408575 0.84 SMN1; SMN2 (0.52) SMN1; SMN2PTGESMEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049604-A1 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback